Skip to main content
Explore URMC
URMC / Mary Parkes Center / News and Events


News and Events

Please Save the Date: November 3, 2022

The 26th Annual Asthma & Allergy Update will be a day-long CME educational event designed to provide physicians, advanced practice providers, respiratory therapists, social workers, and nurses in the community with an update in the field of asthma and allergy. Venue TBD.


25th Annual Asthma & Allergy Update

Thursday, November 18, 2021

The 25th Annual Asthma & Allergy Update conference was held on November 18, 2021. The day-long educational conference provides healthcare professionals with an update in the fields of asthma, allergy and other pulmonary topics. The interdisciplinary and inter-professional aspect of this CME activity makes it unique. This year, the conference topics focused on recent advances in the field of mild/moderate asthma including updates from NAEPP/GINA guidelines, the role of allergen immunotherapy, and how to incorporate as-needed ICS/formoterol in practice. Keynote speaker Dr. Elliott Israel provided an update on severe asthma including phenotyping, biomarkers, and novel biologic therapies. This 25th Annual Asthma and Allergy Update was particularly significant as this was the first in-person regional CME event since the start of the pandemic.

25th Annual Asthma and Allergy Update

Daniel Lachant Awarded Research Grant to Study New Way to Monitor Pulmonary Hypertension

Monday, June 14, 2021

Daniel Lachant, DOPulmonary arterial hypertension is a rare, life-threatening disorder characterized by high blood pressure in the arteries of the lungs. Current methods for diagnosing this condition can be cumbersome, expensive and not entirely reliable. Daniel Lachant, DO, Associate Director of the Pulmonary Hypertension Program at Mary Parkes Center for Asthma, Allergy and Pulmonary Care, has been awarded a grant (URMC KL2 Scholars Award) to study whether cardiac effort (the number of heart beats required for a person to walk a given distance) is a more sensitive and reliable measure to monitor patients. Dr. Lachant will also develop a remote, mask-free assessment of cardiac effort and heart rate expenditure that patients can perform in the comfort of their own homes.